№ files_lp_4_process_3_133357
File format: docx
Character count: 1818
File size: 459 KB
Supplementary table presenting patient characteristics, tumor staging, biomarker expression, and treatment allocation in a clinical cohort of non-metastatic rectal cancer.
Year:
2026
Study Type:
Supplementary Table
Cohort Size:
76 patients
Treatment Groups:
CRT, I+CRT, Unfront surgery
Parameters Measured:
Age, Gender, Tumor Stage, EMVI, CRM, Lateral Lymph Nodes, CEA, CA19.9, NPS score, Histology, MMR status, CDX2 expression, HER2/Neu expression, CD3-CD8 TILs density, PD-L1 expression, Perineural invasion, Vascular invasion, pEMVI, pCRM
Data Source:
Clinical records and histopathological analysis
Statistical Significance:
p-values provided for each parameter
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
[Insert year]
Region / city:
[Insert region/city]
Subject:
Medical treatment request
Document type:
Authorization request letter
Institution:
[Insert institution name]
Author:
[Physician’s name]
Target audience:
Medical/Pharmacy Director
Effective period:
[Insert effective period]
Approval date:
[Insert approval date]
Date of modifications:
[Insert modification date]
Diagnosis:
[Insert diagnosis]
Treatment:
ERLEADA® (apalutamide)
Clinical trial:
TITAN trial
Clinical guidelines reference:
NCCN Guidelines®, AUA/SUO Guidelines
Patient history:
[Insert patient history]
Risk of disease progression:
[Insert risk]
Adverse reactions:
Rash, hot flush, hypertension, arthralgia, pruritus
Publication reference:
Journal of Clinical Oncology
Study data source:
Precision Point Specialty (PPS) Analytics, Komodo Research Database
Study design:
Retrospective, longitudinal, head-to-head analysis
Outcome:
Overall survival at 24 months
Year:
2023
Region:
Global
Topic:
Medical research
Document type:
Research table
Institution:
Not specified
Author:
Not specified
Target audience:
Medical professionals, researchers
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Note:
Contextual description
Document type:
Supplementary table
Study cohort:
Rotterdam cohort
Topic:
Clinicopathological characteristics and treatment response
Medical field:
Oncology
Variables described:
Age, tumor characteristics, response to first-line tamoxifen
Subgroups:
ISGHIGH, ISGLOW
Statistical analysis:
Statistical tests for subgroup differences indicated for each variable
Treatment referenced:
First-line tamoxifen
Population:
Patients included in the Rotterdam cohort
Section:
Supplementary material
Table number:
2
Document type:
Supplemental digital content
Content components:
Figures and tables
Subject area:
Oncology
Research focus:
Survival analysis and clinicopathological characteristics
Clinical variables:
Retrieved lymph nodes, chemoradiotherapy, adjuvant therapy, tumor stage and size
Patient groups:
N0 and N1 patients
Data sources:
WUH cohort and SEER cohort
Institutions / databases:
Wuhan Union Hospital; Surveillance, Epidemiology, and End Results program
Measured outcomes:
Overall survival and prognostic differences
Clinical treatments analyzed:
Chemotherapy, radiotherapy, chemoradiotherapy
Population characteristics:
Age, sex, BMI, tumor grade, tumor stage, tumor size, nerve invasion, vascular invasion
Tables included:
Clinicopathological features before and after propensity score matching
Figures included:
Survival curves and cutoff value analyses for retrieved lymph nodes
Source section:
Table 3
Disease:
Gastric gastrointestinal stromal tumor (GIST)
Biomarker:
DNM3OS expression
Variables analyzed:
Gender; Age; Tumor size; Mitotic count; NIH risk classification; Mutational status; Prior TKI treatment
Sample size:
251 patients
Low expression group:
n=143
High expression group:
n=108
Mutation analysis subset:
n=130
Statistical methods:
P value comparison; Fisher exact test
Genetic markers:
KIT exon 9/11; PDGFRA exon 18; WT
Clinical parameters:
Tumor size (cm); Mitotic count per 50 HPFs; NIH risk classification categories
Therapeutic variable:
Prior tyrosine kinase inhibitor (TKI) treatment
Field of study:
Oncology; Molecular pathology
Year:
2023
Region:
China
Subject:
Male rectal cancer, laparoscopic surgery, postoperative urogenital function
Document Type:
Clinical trial protocol
Organization:
Sun Yat-sen University, Multiple affiliated hospitals
Author:
Research Team
Target Audience:
Medical professionals, researchers, clinicians
Period of Action:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Theme:
Colon and Rectal Surgery Accreditation
Document Type:
Accreditation Application
Institution / Organization:
ACGME
Context:
A document related to the accreditation process for a colon and rectal surgery program, detailing questions for compliance with educational and clinical requirements.
Year:
2020
Specialty:
Colon and Rectal Surgery
Document Type:
Supplemental Guide
Related Framework:
Milestones
Issuing Organization:
Accreditation Council for Graduate Medical Education (ACGME)
Intended Audience:
Clinical Competency Committees and Faculty
Scope:
Patient Care, Medical Knowledge, Systems-Based Practice, Practice-Based Learning and Improvement, Professionalism, Interpersonal and Communication Skills
Focus Areas:
Rectal Cancer, Colonic Neoplasia, Anal Cancer, Benign Anorectal Disease, Inflammatory Bowel Disease, Endoscopy, Pelvic Floor Disorders
Assessment Methods:
Case-Based Presentation, Direct Observation, Medical Record Review, Multisource Feedback, OSCE
Educational Resources Referenced:
ASCRS Textbook of Colon and Rectal Surgery; NCCN Guidelines; American Joint Committee on Cancer Staging Manual
Purpose:
Guidance and examples for evaluation of trainee performance across milestone levels
Year:
2015
Date:
21 November 2015
Type of document:
Letter to the editor
Journal:
Annals of Gastroenterology
Authors:
Nikolaos Gouvas, I. Boukovinas, J. Souglakos, E. Xynos
Recipient:
Prof. I. Koutroubakis, Editor
Subject:
Response to editorial comments on rectal cancer surgical guidelines
Field:
Gastroenterology, Oncology
Purpose:
Clarification of manuscript revision and submission status
Year:
2026
Region / City:
N/A
Topic:
Veterinary care
Document type:
Instruction manual
Organization:
N/A
Author:
N/A
Target audience:
Pet owners
Period of validity:
N/A
Approval date:
N/A
Amendment date:
N/A